Description
Genomtec ID is a flagship technological solution currently
under development, which will offer patients ultrafast mobile genetic diagnosis
utilizing SNAAT®. The Genomtec ID platform makes it possible to run a
diagnostic process at point of care, i.e., public clinics, consulting rooms,
hospital, pharmacies and emergency wards, without the need of complicated and
time-consuming handling by skilled personnel in the laboratory.
The platform includes an analyzer and reaction card with
integrated genetic tests and provides multiplexing capability of up to five
genetic targets at the same time. SARS-CoV-2 will be included in one of the
Genomtec ID’s diagnostic panels intended for identification of respiratory
diseases.
